These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

302 related items for PubMed ID: 1434526

  • 1. Hyperglycemia and microangiopathy. Direct regulation by glucose of microvascular cells.
    Kreisberg JI.
    Lab Invest; 1992 Oct; 67(4):416-26. PubMed ID: 1434526
    [No Abstract] [Full Text] [Related]

  • 2. [The significance of compensation in diabetes mellitus in the development of diabetic microangiopathies (a review of the literature)].
    Gendeleka GF.
    Vrach Delo; 1989 Aug; (8):54-8. PubMed ID: 2686158
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Microvascular complications in cystic fibrosis-related diabetes.
    Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, Moran A.
    Diabetes Care; 2007 May; 30(5):1056-61. PubMed ID: 17322485
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetic microvascular complications and growth factors.
    Pfeiffer A, Schatz H.
    Exp Clin Endocrinol Diabetes; 1995 May; 103(1):7-14. PubMed ID: 7621107
    [Abstract] [Full Text] [Related]

  • 10. Endothelins: regulators of extracellular matrix protein production in diabetes.
    Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, Chan BM, Uniyal S, Chakrabarti S.
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1022-9. PubMed ID: 16741042
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Maillard reaction products and chronic diabetic complications].
    Trivin F, Chevenne D, Hautecouverture M.
    Ann Biol Clin (Paris); 1999 Jun; 57(4):445-54. PubMed ID: 10432367
    [No Abstract] [Full Text] [Related]

  • 13. The biochemistry of the complications of diabetes mellitus.
    Brownlee M, Cerami A.
    Annu Rev Biochem; 1981 Jun; 50():385-432. PubMed ID: 6168237
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease.
    Ziyadeh FN.
    Miner Electrolyte Metab; 1995 Jun; 21(4-5):292-302. PubMed ID: 7565478
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The role of angiogenic growth factors in the development of diabetic complications].
    Siebert J, Reiwer-Gostomska M.
    Kardiol Pol; 2009 Jan; 67(1):62-4. PubMed ID: 19253193
    [No Abstract] [Full Text] [Related]

  • 18. [Diabetic microangiopathy--its biochemical bases].
    Kawazu S, Tomono S.
    Nihon Rinsho; 1991 Feb; 49 Suppl():34-42. PubMed ID: 1827848
    [No Abstract] [Full Text] [Related]

  • 19. [The effect of metabolic control on the development of late complications of diabetes (author's transl)].
    Willms B.
    MMW Munch Med Wochenschr; 1977 Apr 15; 119(15):482-8. PubMed ID: 405563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.